Anthera Pharmace Stock Price, News & Analysis
Company Description
Anthera Pharmace (OTC Link: ANTH) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $617.8K.
ANTH stock has declined 100.0% over the past year. Shares last traded at $0.0010.
This page provides a comprehensive overview of ANTH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Anthera Pharmace (ANTH) stock last traded at $0.0010, down 99.90% from the previous close. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $617.8K, ANTH is classified as a micro-cap stock with approximately 26.2M shares outstanding.
Latest News
Anthera Pharmace has 1 recent news article. Key topics include acquisition. View all ANTH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Anthera Pharmace (ANTH) currently stands at 3.0 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 10.4%. This relatively low short interest suggests limited bearish sentiment. With 17.3 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Anthera Pharmace (ANTH) currently stands at 17.3 days, up 95.4% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 1629% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 27.2 days.
ANTH Company Profile & Sector Positioning
Anthera Pharmace (ANTH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ANTH often look at related companies in the same sector, including Theralink Technologies Inc (THER), Claritas Pharmac (CLAZF), Regen Biopharma (RGBP), Hepion Pharmaceuticals Inc (HEPA), and SYBLEU Inc (SYBE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ANTH's relative position within its industry.